Sonic Healthcare CEO Colin Goldschmidt to retire after 32 years
Make us a preferred source
Make us a preferred source on Google
The news: Pathology provider Sonic Healthcare has announced that managing director and chief executive Colin Goldschmidt will retire in November after 32 years in the role.
He will be replaced by Jim Newcombe, who joined Sonic eight years ago and is currently the CEO of Sonic's founding practice Douglass Hanly Moir Pathology in Sydney.
The context: Goldschmidt will retire at the company's annual general meeting on 20 November, but will remain an adviser to the Sonic board in a part-time, unpaid capacity. He will also continue to chair the Sonic Healthcare Foundation board.
As Newcombe moves into the role of CEO, Sonic will see Evangelos Kotsopoulos take the newly created position of chief operating officer. Kotsopoulos is currently CEO of Sonic Healthcare Europe and Sonic Healthcare Germany, overseeing the company's operations in Germany, Switzerland and Belgium. He joined Sonic in 2007 after a career in investment banking.
What they said: "After thirty-two years as Sonic's CEO, Colin has decided it is the right time to retire, and the board respects his decision," said Sonic chairman Mark Compton.
"Colin has led Sonic's expansion from a single laboratory in Sydney onto the global stage to become the third largest pathology player in the world by developing and committing the company to the culture of medical leadership."
Goldschmidt commented: "While the decision to retire was never an easy one, the time is now right. The company is in a very strong position, both culturally and financially, and is well set for ongoing growth."
The source: ASX
